You are here: Industry Insights > Pfizer

News List

Teva's EpiPen generic retails for same price as Mylan's own pharmafile
November 29, 2018
Israeli generics firm Teva has revealed the price tag of its generic version of Mylan’s EpiPen epinephrine auto-injector, and, at $300 wholesale for a pack of two,
Pfizer doubles down in AML with Daurismo approval fiercepharma
November 28, 2018
Make that four drug approvals for Pfizer’s oncology unit in less than two months. In a welcome streak for the pharma giant—what with Lyrica generics looming—the FDA handed out a go-ahead for Daurismo, a treatment for acute myeloid leukemia.
Aileron, Pfizer in Clinical Collaboration contractpharma
November 28, 2018
To evaluate the combination of Aileron’s ALRN-6924 and Pfizer’s IBRANCE in cancer
AbbVie, Roche take Venclexta into AML arena fiercepharma
November 27, 2018
AbbVie and Roche’s Venclexta is leaving familiar territory with its latest approval, and it won’t be an easy land grab. To establish itself on its new turf, the blood cancer drug will have to duke it out with some Big Pharma rivals.
Pfizer to hike prices of 41 drugs despite Trump criticism pharmaphorum
November 27, 2018
Pfizer plans to raise the prices of 41 prescription drugs in January, despite falling foul of President Trump, who criticised the company’s stance on costs earlier this summer.
Pfizer, Eli Lilly’s non-opioid drug helps reduce osteoarthritis pain biospectrumasia
November 26, 2018
A non-opioid drug developed by Pfizer and Eli Lilly met the main goals of a late-stage study, in which over half of the patients reported a significant reduction in osteoarthritis pain of the knee or hip.
Pfizer, Merck KGaA's Bavencio flunks ovarian cancer trial fiercepharma
November 26, 2018
Monday, the drugmakers reported that their immuno-oncology drug had failed a phase 3 trial in previously treated ovarian cancer patients, failing to stave off cancer progression or prolong life either on its own or in tandem with chemo.
Pfizer ask Senator Cindy Hyde-Smith to refund campaign donation after 'public hanging' comments pharmafile
November 22, 2018
American pharma giant Pfizer have asked Mississippi Republican Senator Cindy Hyde-Smith to return campaign donations after the candidate was filmed joking about attending a “public hanging”.
Merck KGaA and Pfizer's Bavencio falls short in ovarian cancer pharmafile
November 21, 2018
Merck KGaA and Pfizer’s Bavencio (avelumab) has missed its primary endpoints in the treatment of platinum-resistant or -refractory ovarian cancer, whether as a monotherapy or in combination with chemotherapy.
Merck and Pfizer provide update on avelumab in platinum-resistant/refractory ovarian cancer worldpharmanews
November 21, 2018
Merck and Pfizer Inc. (NYSE: PFE) today announced that the Phase III JAVELIN Ovarian 200 trial evaluating avelumab* alone or in combination with pegylated liposomal doxorubicin (PLD)

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page